Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gender effect on alfentanil effective dose for painless bronchoscopy
ChiCTR2000035855Phase 4Not yet recruiting
- Sponsor
- Taizhou Hospital of Zhejiang Province
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of alfentanil, sponsored by Taizhou Hospital of Zhejiang Province. Primary endpoints: Bronchoscope score and Oxygen saturation. Planned start Aug 2020; status: not yet recruiting.
02
Drugs
alfentanil
Beyond the preview
Go deeper on ChiCTR2000035855.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000035855.